"Dedifferentiation" and High-Grade Transformation in Salivary Gland Carcinomas

Head and Neck Pathology

Volumn 7, Issue SUPPL 1, 2013, Pages 37-47

  Nagao, Toshitaka ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Acinic cell carcinoma; Adenoid cystic carcinoma; Dedifferentiation; High grade transformation; Pathology; Salivary gland

Indexed keywords

TUMOR MARKER;

ARTICLE; CANCER GRADING; CELL DEDIFFERENTIATION; CELL TRANSFORMATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; SALIVARY GLAND TUMOR;

CELL DEDIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASM GRADING; PROGNOSIS; SALIVARY GLAND NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84880764103     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-013-0458-8     Document Type: Article

References (71)

1. Dahlin DC, Beabout JW. Dedifferentiation of low-grade chondrosarcomas. Cancer. 1971;28: 461-6.
2. Meis JM. "Dedifferentiation" in bone and soft-tissue tumors: a histological indicator of tumor progression. Pathol Annu. 1991;26: 37-62.
3. Stanley RJ, Weiland LH, Olsen KD, et al. Dedifferentiated acinic cell (acinous) carcinoma of the parotid gland. Otolaryngol Head Neck Surg. 1988;98: 155-61.
4. El-Naggar AK, Batsakis JG, Luna MA, et al. DNA flow cytometry of acinic cell carcinomas of major salivary glands. J Laryngol Otol. 1990;104: 410-6.
5. Nunes JF, Fonseca I, Soares J. Helioid inclusions in dedifferentiated acinic cell carcinoma of the parotid gland. Ultrastruct Pathol. 1996;20: 443-9.
6. Henley JD, Geary WA, Jackson CL, et al. Dedifferentiated acinic cell carcinoma of the parotid gland: a distinct rarely described entity. Hum Pathol. 1997;28: 869-73.
7. Di Palma S, Corletto V, Lavarino C, et al. Unilateral aneuploid dedifferentiated acinic cell carcinoma associated with bilateral-low grade diploid acinic cell carcinoma of the parotid gland. Virchows Arch. 1999;434: 361-5.
8. Timon CI, Dardick I. The importance of dedifferentiation in recurrent acinic cell carcinoma. J Laryngol Otol. 2001;115: 639-44.
9. Piana S, Cavazza A, Pedroni C, et al. Dedifferentiated acinic cell carcinoma of the parotid gland with myoepithelial features. Arch Pathol Lab Med. 2002;126: 1104-5.
10. Schultz AM, Thomas AB, Henley JD, et al. Pathologic quiz case: a 42-year-old man with right facial swelling and weakness. Dedifferentiated acinic cell carcinoma of the parotid gland. Arch Pathol Lab Med. 2004;128: e52-3.
11. González-Peramato P, Jiménez-Heffernan JA, López-Ferrer P, et al. Fine needle aspiration cytology of dedifferentiated acinic cell carcinoma of the parotid gland: a case report. Acta Cytol. 2006;50: 105-8.
12. Skálová A, Sima R, Vanecek T, et al. Acinic cell carcinoma with high-grade transformation: a report of 9 cases with immunohistochemical study and analysis of TP53 and HER-2/neu genes. Am J Surg Pathol. 2009;33: 1137-45.
13. Johnykutty S, Miller CH, Hoda RS, et al. Fine-needle aspiration of dedifferentiated acinic cell carcinoma: report of a case with cyto-histological correlation. Diagn Cytopathol. 2009;37: 763-8.
14. Hyun OJ, Yoo IeR, Jung CK, et al. F-18 FDG PET/CT findings of dedifferentiated acinic cell carcinoma. Clin Nucl Med. 2010;35: 473-4.
15. Chiosea SI, Griffith C, Assaad A, et al. The profile of acinic cell carcinoma after recognition of mammary analog secretory carcinoma. Am J Surg Pathol. 2012;36: 343-50.
16. Cheuk W, Chan JK, Ngan RK. Dedifferentiation in adenoid cystic carcinoma of salivary gland: an uncommon complication associated with an accelerated clinical course. Am J Surg Pathol. 1999;23: 465-72.
17. Moles MA, Avila IR, Archilla AR. Dedifferentiation occurring in adenoid cystic carcinoma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999;88: 177-80.
18. Chau Y, Hongyo T, Aozasa K, et al. Dedifferentiation of adenoid cystic carcinoma: report of a case implicating p53 gene mutation. Hum Pathol. 2001;32: 1403-7.
19. Nagao T, Gaffey TA, Serizawa H, et al. Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol. 2003;16: 1265-72.
20. Sato K, Ueda Y, Sakurai A, et al. Adenoid cystic carcinoma of the maxillary sinus with gradual histologic transformation to high-grade adenocarcinoma: a comparative report with dedifferentiated carcinoma. Virchows Arch. 2006;448: 204-8.
21. Seethala RR, Hunt JL, Baloch ZW, et al. Adenoid cystic carcinoma with high-grade transformation: a report of 11 cases and a review of the literature. Am J Surg Pathol. 2007;31: 1683-94.
22. Handra-Luca A, Planchard D, Fouret P. Docetaxel-cisplatin-radiotherapy in adenoid cystic carcinoma with high-grade transformation. Oral Oncol. 2009;45: e208-9.
23. Malhotra KP, Agrawal V, Pandey R. High grade transformation in adenoid cystic carcinoma of the parotid: report of a case with cytologic, histologic and immunohistochemical study. Head Neck Pathol. 2009;3: 310-4.
24. Bonfitto VL, Demasi AP, Costa AF, et al. High-grade transformation of adenoid cystic carcinomas: a study of the expression of GLUT1 glucose transporter and of mitochondrial antigen. J Clin Pathol. 2010;63: 615-9.
25. Panarelli JF, Zoumalan CI, Mukkamala K, et al. Dedifferentiated adenoid cystic carcinoma of the lacrimal gland. Ophthal Plast Reconstr Surg. 2011;27: e119-21.
26. Boland JM, McPhail ED, García JJ, et al. Detection of human papilloma virus and p16 expression in high-grade adenoid cystic carcinoma of the head and neck. Mod Pathol. 2012;25: 529-36.
27. Argyris PP, Pambuccian SE, Cayci Z, et al. Lacrimal gland adenoid cystic carcinoma with high-grade transformation to myoepithelial carcinoma: Report of a case and review of literature. Head Neck Pathol. 2013;7: 85-92.
28. Simpson RH, Clarke TJ, Sarsfield PT, et al. Epithelial-myoepithelial carcinoma of salivary glands. J Clin Pathol. 1991;44: 419-23.
29. Alos L, Carrillo R, Ramos J, et al. High-grade carcinoma component in epithelial-myoepithelial carcinoma of salivary glands clinicopathological, immunohistochemical and flow-cytometric study of three cases. Virchows Arch. 1999;434: 291-9.
30. Fonseca I, Félix A, Soares J. Dedifferentiation in salivary gland carcinomas. Am J Surg Pathol. 2000;24: 469-71.
31. Manuel S, Mathews A, Chandramohan K, et al. Carcinosarcoma of the parotid gland with epithelial-myoepithelial carcinoma and pleomorphic sarcoma components. Br J Oral Maxillofac Surg. 2002;40: 480-3.
32. Nagao T, Sugano I, Ishida Y, et al. Hybrid carcinomas of the salivary glands: report of nine cases with a clinicopathologic, immunohistochemical, and p53 gene alteration analysis. Mod Pathol. 2002;15: 724-33.
33. Seethala RR, Barnes EL, Hunt JL. Epithelial-myoepithelial carcinoma: a review of the clinicopathologic spectrum and immunophenotypic characteristics in 61 tumors of the salivary glands and upper aerodigestive tract. Am J Surg Pathol. 2007;31: 44-57.
34. Kusafuka K, Takizawa Y, Ueno T, et al. Dedifferentiated epithelial-myoepithelial carcinoma of the parotid gland: a rare case report of immunohistochemical analysis and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008;106: 85-91.
35. Niederhagen M, Zengel P, Ihrler S. Secondary high-malignant transformation of a low-malignant epithelial-myoepithelial carcinoma. Pathologe. 2009;30: 461-5.
36. Roy P, Bullock MJ, Perez-Ordoñez B, et al. Epithelial-myoepithelial carcinoma with high grade transformation. Am J Surg Pathol. 2010;34: 1258-65.
37. Sarode VR, Truelson J, Zaidie M. Dedifferentiated epithelial-myoepithelial carcinoma of the parotid gland with aberrant expression of prostate specific antigen: a case report. Int J Surg Pathol. 2010;18: 401-5.
38. Suzuki T, Murata S, Yamaguchi H, et al. Epithelial-myoepithelial carcinoma with myoepithelial anaplasia: report of a case with cytologic findings of a rare variant. Acta Cytol. 2010;54: 605-10.
39. Park JO, Jung CK, Sun DI, et al. An unusual presentation of aggressive epithelial-myoepithelial carcinoma of the nasal cavity with high-grade histology. J Laryngol Otol. 2011;125: 1286-9.
40. Lima FJ, Porto DE, Cavalcante JR, et al. Epithelial-myoepithelial carcinoma of high grade transformation: the case report in the buccal mucosa. Open Dent J. 2012;6: 111-7.
41. Yang S, Chen X. Epithelial-myoepithelial carcinoma with high grade transformation. Int J Oral Maxillofac Surg. 2012;41: 810-3.
42. Baker AR, Ohanessian SE, Adil E, et al. Dedifferentiated epithelial-myoepithelial carcinoma: Analysis of a rare entity based on a case report and literature review. Int J Surg Pathol (in press).
43. Mills SE, Garland TA, Allen MS Jr. Low-grade papillary adenocarcinoma of palatal salivary gland origin. Am J Surg Pathol. 1984;8: 367-74.
44. Lloreta J, Serrano S, Corominas JM, et al. Polymorphous low-grade adenocarcinoma arising in the nasal cavities with an associated undifferentiated carcinoma. Ultrastruct Pathol. 1995;19: 365-70.
45. Pelkey TJ, Mills SE. Histologic transformation of polymorphous low-grade adenocarcinoma of salivary gland. Am J Clin Pathol. 1999;111: 785-91.
46. Simpson RH, Pereira EM, Ribeiro AC, et al. Polymorphous low-grade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma. Histopathology. 2002;41: 250-9.
47. Ogawa I, Nishida T, Miyauchi M, et al. Dedifferentiated malignant myoepithelioma of the parotid gland. Pathol Int. 2003;53: 704-9.
48. Nagao T, Gaffey TA, Kay PA, et al. Dedifferentiation in low-grade mucoepidermoid carcinoma of the parotid gland. Hum Pathol. 2003;34: 1068-72.
49. Subramaniam MM, Ng SB, Seah SB, et al. Molecular characterization of dedifferentiated mucoepidermoid carcinoma of the trachea using laser microdissection-based TP53 mutation analysis. Histopathology. 2009;55: 472-5.
50. O'Regan E, Shandilya M, Gnepp DR, et al. Hyalinizing clear cell carcinoma of salivary gland: an aggressive variant. Oral Oncol. 2004;40: 348-52.
51. Jin R, Craddock KJ, Irish JC, et al. Recurrent hyalinizing clear cell carcinoma of the base of tongue with high-grade transformation and EWSR1 gene rearrangement by FISH. Head Neck Pathol. 2012;6: 389-94.
52. Costa AF, Altemani A, Hermsen M. Current concepts on dedifferentiation/high-grade transformation in salivary gland tumors. Patholog Res Int. 2011;2011: 325965.
53. Barnes EL, Eveson JW, Reichart P, Sidransky D, editors. Pathology and genetics of head and neck tumours. Kleihues P, Sobin LH, series editors. World Health Organization Classification of Tumours. Lyon, France: IARC Press, 2005.
54. Eveson JW, Nagao, T. Chapter 10. Diseases of the salivary glands. In: Barnes L, editor. Surgical pathology of the head and neck. New York: Informa Healthcare; 2009. p. 475-648.
55. Gnepp DR, Henley JD, Simpson RHW, Eveson JW. Salivary and lacrimal glands. In: Gnepp DR, editor. Diagnostic surgical pathology of the head and neck. Philadelphia: Saunders; 2009. p. 413-562.
56. Kamio N, Tanaka Y, Mukai M, et al. A hybrid carcinoma: adenoid cystic carcinoma and salivary duct carcinoma of the salivary gland: an immunohistochemical study. Virchows Arch. 1997;430: 495-500.
57. Snyder ML, Paulino AF. Hybrid carcinoma of the salivary gland: salivary duct adenocarcinoma adenoid cystic carcinoma. Histopathology. 1999;35: 380-3.
58. Zardawi IM. Hybrid carcinoma of the salivary gland. Histopathology. 2000;37: 283-4.
59. Costa AF, Tasso MG, Mariano FV, et al. Levels and patterns of expression of hypoxia-inducible factor-1α, vascular endothelial growth factor, glucose transporter-1 and CD105 in adenoid cystic carcinomas with high-grade transformation. Histopathology. 2012;60: 816-25.
60. Costa AF, Altemani A, Vékony H, et al. Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type. Cell Oncol (Dordr). 2011;34: 369-79.
61. Seethala RR, Cieply K, Barnes EL, et al. Progressive genetic alterations of adenoid cystic carcinoma with high-grade transformation. Arch Pathol Lab Med. 2011;135: 123-30.
62. Persson M, Andrén Y, Mark J, et al. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA. 2009;106: 18740-4.
63. Mitani Y, Li J, Rao PH, et al. Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: incidence, variability, and clinicopathologic significance. Clin Cancer Res. 2010;16: 4722-31.
64. West RB, Kong C, Clarke N, et al. MYB expression and translocation in adenoid cystic carcinomas and other salivary gland tumors with clinicopathologic correlation. Am J Surg Pathol. 2011;35: 92-9.
65. Tonon G, Modi S, Wu L, et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet. 2003;33: 208-13.
66. Anzick SL, Chen WD, Park Y, et al. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer. 2010;49: 59-69.
67. Clauditz TS, Gontarewicz A, Wang CJ, et al. 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma. Diagn Mol Pathol. 2012;21: 134-7.
68. Jee KJ, Persson M, Heikinheimo K, et al. Genomic profiles and CRTC1-MAML2 fusion distinguish different subtypes of mucoepidermoid carcinoma. Mod Pathol. 2013;26: 213-22.
69. Milchgrub S, Gnepp DR, Vuitch F, et al. Hyalinizing clear cell carcinoma of salivary gland. Am J Surg Pathol. 1994;18: 74-82.
70. O'Sullivan-Mejia ED, Massey HD, Faquin WC, et al. Hyalinizing clear cell carcinoma: report of eight cases and a review of literature. Head Neck Pathol. 2009;3: 179-85.
71. Antonescu CR, Katabi N, Zhang L, et al. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland. Genes Chromosomes Cancer. 2011;50: 559-70.